EMA recommends cell-based therapy to reduce complications from stem cell transplants – The Pharmaceutical Journal
The Pharmaceutical Journal |
EMA recommends cell-based therapy to reduce complications from stem cell transplants
The Pharmaceutical Journal A genetically modified cell-based therapy that can reduce the risk of complications following a stem cell transplant in patients with certain blood cancers has been recommended for conditional marketing authority by the European Medicines Agency (EMA). |
